Quality & complianceGuideline · final

MHRA updates IDAP page as one Unmet Clinical Need Authorisation is closed

🇬🇧 MHRA · Thu 19 Nov 2026

The UK regulator has revised its Innovative Devices Access Pathway guidance to show that authorisation IDAP/DEU/009/2024/0001 is closed, while the pilot itself stays shut to new applicants.

The Medicines and Healthcare products Regulatory Agency (MHRA) updated its Innovative Devices Access Pathway (IDAP) guidance page on 19 November 2026. The change revises the attached Unmet Clinical Need Authorisation (UCNA) document to show that IDAP/DEU/009/2024/0001 has been closed. The page does not say which product the reference covers or why it was closed.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official guideline text: MHRA ↗

Article written by VigiEye from the official source (MHRA). AI-assisted; check the source before acting.